References
- Altmann, K. H., Gertsch, J. (2007). Anticancer drugs from nature—natural products as a unique source of new microtubule-stabilizing agents. Nat Prod Rep 24:327–357.
- Atas, A., Ağca, O., Saraç, S., Poyraz, A., Akyol, M. U. (2006). Investigation of ototoxic effects of taxol on a mice model. Int J Pediatr Otorhinolaryngol 70:779–784.
- Aydinli, B., Kantarci, M., Polat, K. Y., Unal, B., Atamanalp, S. S., Durur, I., et al. (2006). Stereological evaluation of treatment response in patients with nonresectable hepatic alveolar echinococcosis using computed tomography via the Cavalieri method. Liver Int 26:1234–1240.
- Bancroft, J. D., Stevens, A. (1996). Theory and practice of histological techniques, 4th ed. (p136). Churchill Livingstone Medical Division of Pearson Professional Lmt, New York, USA.
- Brown, G. D., Gordon, S. (2003). Fungal β-glucans and mammalian immunity. Immunity 19:311–315.
- Bell, S. J., Goldman, V. M., Bistrian, B. R., Arnold, A. H., Ostroff, G., Forse, R. A. (1999). Effect of β-glucan from oats and yeast on serum lipids. Crit Rev Food Sci Nutr 39:189–202.
- Cleary, J. A., Kelly, G. E., Husband, A. J. (1999). The effect of molecular weight and β-1,6-linkages on priming of macrophage function in mice by (1,3)-β-d-glucan. Immunol Cell Biol 77:395–403.
- Crosasso, P., Ceruti, M., Brusa, P., Arpicco, S., Dosio, F., Cattel, L. (2000). Preparation, characterization, and properties of sterically stabilized paclitaxel-containing liposomes. J Contr Rel 63:19–30.
- Delaney, B., Carlson, T., Frazer, S., Zheng, T., Hess, R., Ostergren, K., et al. (2002). Evaluation of the toxicity of concentrated barley β-glucan in a 28-day feeding study in Wistar rats. Food Chem Toxicol 41:477–487.
- Delatte, S. J., Evans, J., Hebra, A., Adamson, W., Othersen, H. B., Tagge, E. P. (2001). Effectiveness of beta-glucan collagen for treatment of partial-thickness burns in children. J Pediatr Surg 36:113–118.
- Engstad, C. S., Engstad, R. E., Olsen, J. O., Osterud, B. (2002). The effect of soluble β-1,3-glucan and lipopolysaccharide on cytokine production and coagulation activation in whole blood. Int Immunopharmacol 2:1585–1597.
- Ermolaeva, L. A., Dubskaya, T. Y., Fomina, T. I., Vetoshkina, T. V., Goldberg, V. E. (2008). Toxic effect of an antitumor drug, paclitaxel, on morphofunctional characteristics of the liver in rats. Bull Exp Biol Med 145:263–265.
- Gardiner, T. (2000). A review: Beta-glucan biological activities. GlycoScience 1:1–6.
- Glaser, J., Green, G., Hendricks, S. (2007). Stereology for biological research with a focus on neuroscience, 2nd ed. Williston, Vermont, USA: MBF Press
- Gundersen, H. J. G., Jensen, E. B. (1987). The efficiency of systematic sampling in stereology and its prediction. J Microsc 147:229–263.
- Guo, W., Johnson, J. L., Khan, S., Ahmad, A., Ahmad, I. (2005). Paclitaxel quantitation in mouse plasma and tissues containing liposome-entrapped paclitaxel by liquid chromatography–tandem mass spectrometry: application to a pharmacokinetics study. Anal Biochem 336:213–220.
- Halici, Z., Suleyman, H., Cadirci, E. (2008). Effects of calcium channel blockers on hyaluronidase-induced capillary vascular permeability. Arch Pharm Res 31(7):891–9.
- Halici, Z., Keles, O. N., Unal, D., Albayrak, M., Suleyman, H., Cadirci, E., et al. (2008). Chronically administered risperidone did not change the number of hepatocytes in rats: a stereological and histopathological study. Basic Clin Pharmacol Toxicol 102:426–432.
- Halici, Z., Dursun, H., Keles, O. N., Odaci, E., Suleyman, H., Aydin, N., et al. (2009). Effect of chronic treatment of haloperidol on the rat liver: a stereological and histopathological study. Naunyn Schmiedebergs Arch Pharmacol 379:253–261.
- Halliwell, B., Gutteridge, J. M. C. (1990). Role of free radicals and catalytic metal ions in human disease: an overview. Meth Enzymol 186:1–85.
- Hashimoto, T., Ohno, N., Adachi, Y., Yadomae, T. (1997). Enhanced production of inducible nitric oxide synthase by β-glucans in mice. FEMS Immunol Med Microbiol 19:131–135.
- Kaiser, A. B., Kernoddle, D. S. (1998). Synergism between poly-[1-6]-β-d-glucopyranosyl-[1-3]-β-d-glucopyranose glucan and cefazolin in prophylaxis of staphylococcal wound infection in a guinea pig model. Antimicrob Agents Chemother 42:2449–2451.
- Keller, T. (2000). Compounding with β-1,3—glucan. Int J Pharmaceut Compound 4:342–345.
- Kernoddle, D. S., Gates, H., Kaiser, A. B. (1998). Prophylactic anti-infective activity of poly-[1-6]-β-D-glucopyranosyl-[1-3]-β-D-glucopyranose glucan in a guinea pig model of staphylococcal wound infection. Antimicrob Agents Chemother 42:545–549.
- Kim, S. C., Kim, D. W., Shim, Y. H., Bang, J. S., Oh, H. S., Kim, S. W., et al. (2001). In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy. J Contr Rel 72:191–202.
- Kogan, G., Sandula, J., Korolenko, T. A., Falameeva, O. V., Poteryaeva, O. N., Zhanaeva, S. Y., et al. (2002). Increased efficiency of Lewis lung carcinoma chemotherapy with a macrophage stimulator—yeast carboxymethyl glucan. Int Immunopharmacol 2:775–781.
- Kovacs, P., Csaba, G., Pallinger, E., Czaker, R. (2007). Effects of taxol treatment on the microtubular system and mitochondria of tetrahymena. Cell Biol Int 31:724–732.
- Krol, T. (1998). Activity of lysosomal system in mouse liver after taxol administration. Gen Pharmacol 30:239–243.
- Li, T., Hu, J., Thomas, J. A., Li, L. (2005). Differential induction of apoptosis by LPS and taxol in monocytic cells. Mol Immunol 42:1049–1055.
- Liang, J., Melican, D., Cafro, L., Place, G., Fisette, L., Armstrong, R., et al., (1998). Enhanced clearance of a multiple antibiotic resistant Staphylococcus aureus in rats treated with PGG-glucan is associated with increased leukocyte counts and increased neutrophil oxidative burst activity. Int J Immunopharmacol 20:595–614.
- Ljungman, A. G., Leanderson, P., Tagesson, C. (1998). (1-3)-β-D-glucan stimulates nitric oxide generation and cytokine mRNA expression in macrophages. Environ Toxicol Pharmacol 5:273–281.
- Nakagawa, Y., Ohno, N., Murai, T. (2003). Suppression by Candida albicans β-glucan of cytokine release from activated human monocytes and from T cells in the presence of monocytes. J Infect Dis 187:710–713.
- Nicolosi, R., Bell, S. J., Bistrian, B. R., Greenberg, I., Forse, R. A., Blackburn, G. L. (1999). Plasma lipid changes after supplementation with β-glucan fiber from yeast. Am J Clin Nutr 70:208–212.
- Onderdonk, A. B., Cisneros, R. L., Hinkson, P., Ostroff, G. (1992). Anti-infective effect of poly-β1-6-glucotriosyl-β1-3-glucopyranose glucan in vivo. Infect Immun 60:1642–1647.
- Rowinsky, E. K, Onetto, N., Canetta, R., Arbuck, S. G. (1992). Taxol, the first of the taxanes. Semin Oncol 19:646–662.
- Rowinsky, E. K., Donehower, R. C. (1995). Paclitaxel (taxol). NEJM 332:1004–1014.
- Russ, J. C., Dehoff, R. T. (1999). Practical stereology, 2nd ed. New York: Plenum Press.
- Sherwood, E. R., Varma, T. K., Framm, R. Y., Lin, C. Y., Koutrouvelis, A. P., Toliver-Kinsky, T. E. (2001). Glucan phosphate potentiates endotoxin-induced interferon-γ expression in immunocompetent mice, but attenuates induction of endotoxin tolerance. Clin Sci 101:541–550.
- Shieh, M., Chu, I., Lee, C., Kan, P., Hau, D., Shieh, J. (1997). Liposomal delivery system for taxol. J Ferment Bioeng 83:87–90.
- Soltys, J., Quinn, M. T. (1999). Modulation of endotoxin- and enterotoxin-induced cytokine release by in vitro treatment with β-(1,6)-branched β-(1,3)-glucan. Infect Immun 67:244–252.
- Sterio, D. C. (1984). The unbiased estimation of number and size of arbitrary particles using the disector. J Microsc 134:127–136.
- Toklu, H. Z., Sener, G., Jahovic, N., Uslu, B., Arbak, S., Yeğen, B. C. (2006). β-glucan protects against burn-induced oxidative organ damage in rats. Int Immunophrmocol 6:156–169.
- Tsiapali, E., Whaley, S., Kalbfleisch, J., Ensley, H. E., Browder, I. W., Williams, D. (2001). Glucans exhibit weak antioxidant activity, but stimulate macrophage free radical activity. Free Radic Biol Med 30:393–402.
- Varbiro, G., Veres, B., Gallyasjr, F., Sumegi, B. (2001). Direct effect of taxol on free radical formation and mitochondrial permeability transition. Free Radic Biol Med 31:548–558.
- Vetvicka, V., Yvin, J. (2004). Effects of marine β-1,3-D-glucan on immune reactions. Int Immunopharmacol 4:721–730.
- Wakui, A., Kasai, M., Konno, K., Abe, R., Kanamaru, R., Takahashi, K., et al. (1986). Randomized study of lentinan on patients with advanced gastric and colorectal cancer. Gan To Kagaku Ryoho 13(4 Pt 1):1050–1059.
- Wei, D., Williams, D., Browder, W. (2002). Activation of AP-1 and SP1 correlates with wound growth factor gene expression in glucan-treated human fibroblasts. Int Immunopharmacol 2:1163–1172.